For in vitro diagnostic use.
Biomarkers can assist with risk stratification, surveillance and diagnosis, as well as predicting and monitoring treatment response or assessing disease progression and recurrence.1 This information should be utilized alongside existing clinical and diagnostic findings to select appropriate treatment interventions for each patient.
With one out of every two people expected to get cancer during their lifetime there is a clear need to optimize diagnostic solutions to tackle key challenges in oncology management.2
A rising number of tests combine the insights derived from two or more biomarkers into an algorithm to generate a result. These are known as multianalyte assays with algorithmic analysis (MAAAs). This combination may help improve performance compared to using single biomarkers.
Abbott offers a wide variety of assays to assist in the risk-stratification, diagnosis and management for many types of cancers including, colon, liver, ovarian, breast, pancreatic, testicular, gastrointestinal, lung and prostate cancer.
The oncology solutions from Abbott can help you reduce laboratory operational costs while maintaining the quality standards necessary to have a meaningful positive impact to the quality and cost of health care.
| Cancer |
| AFP |
| Beta2 Microglobulin |
| CA 125 II |
| CA 15-3 |
| CA 19-9 (CA 19-9 XR) |
| CA 72-4* |
| CEA |
| CYFRA 21-1 |
| HE-4 (ROMA) |
| Immunoglobulin A (IgA) |
| Immunoglobulin E (IgE) |
| Immunoglobulin G (IgG) |
| Immunoglobulin M (IgM) |
| Light Chain Kappa |
| Light Chain Lambda |
| NSE |
| Pepsinogen I |
| Pepsinogen II |
| PIVKA-II |
| ProGRP |
| PSA, Free |
| PSA, Total |
| SCC |
*In development. Not commercially available.
Login or register for a new account on the Lab Central customer portal. Here you can view assay specific package inserts for intended use, important safety information and manage your personalized lab metrics.
Diagnostics at Abbott offers a complete portfolio of integrated solutions including Core Laboratory, Molecular, Point of Care, Rapid Diagnostics and Transfusion Medicine.
Abbott's high-quality immunoassay menu helps laboratories meet requirements to be reliable, accurate and precise.
Learn how Abbott has helped physicians evaluate suspected mild traumatic brain injury (mTBI).
Discover how Alinity uses powerful technology to help redefine and improve operational productivity and confidence in your laboratory.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
